NCT02790853View on ClinicalTrials.gov

Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 25, 2016

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
DysplasiaLip and Oral Cavity CarcinomaOral DisorderPremalignant Lesion
Interventions
PROCEDURE

Biopsy

Undergo brush biopsy and incisional biopsy

PROCEDURE

Fluorescence Imaging

Undergo PS2.1/PS3 imaging

PROCEDURE

High-Resolution Microendoscopy

Undergo HRME imaging

DRUG

Proflavine Hemisulfate

Applied on mucosa

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER